Symbicort, which is used to treat chronic obstructive pulmonary disease and asthma, can cause side effects. Mild side effects include nasal congestion and headaches. Serious side effects include ...
MADISON, Wis.--(BUSINESS WIRE)--Propeller Health, a leading digital health company dedicated to the management of asthma and COPD, today announced it has received 510(k) clearance from the U.S. Food ...
LONDON, June 4 (Reuters) - A new version of AstraZeneca Plc's Symbicort asthma drug, which can be used simultaneously as maintenance and reliever therapy, has been launched in Britain, the company ...